Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Aug 1;69(Suppl 1):S23–S32. doi: 10.1093/cid/ciz396

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America.

This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in anymedium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com

PMC Copyright notice

Figure 3. — Reduction in lesion size from baseline to posttreatment evaluation in mITT population: A, OASIS-1 intravenous to oral study; B, OASIS-2 oral-only study; and C, combined data from OASIS-1 and OASIS-2. In all graphs, omadacycline shows a similar trend to linezolid in lesion size over the study duration. Error bars represent the standard error. Lines are offset horizontally to better visualize the data points. Abbreviations: EOT, end of treatment; mITT, modified intent-to-treat; OASIS, Omadacycline in Acute Skin and Skin Structure Infections Study; PTE, posttreatment evaluation; SE, standard error.